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Abstract:
Background: The States of Consciousness Questionnaire (SOCQ) was developed to assess the occurrence features of the change in consciousness induced 
by psilocybin, and includes the Mystical Experience Questionnaire (MEQ), developed to assess the ocurrence of mystical experiences in altered states of 
consciousness. Objective: To translate the SOCQ to Brazilian Portuguese and validate the 30-item MEQ. Methods: The SOCQ was translated to Brazilian 
Portuguese and backtranslated into English. The two English versions were compared and differences corrected, resulting in a Brazilian translation. Using 
an internet-survey, 1504 Portuguese-speaking subjects answered the translated version of the SOCQ. The 4-factor version of MEQ30 was analyzed using 
confirmatory factor analysis and reliability analysis. Results: A Brazilian Portuguese version of the SOCQ was made available. Goodness-of-fit indexes 
indicated that data met the factorial structure proposed for the English MEQ30. Factors presented excellent to acceptable reliability according to Cronbach’s 
alpha: mystical (0.95); positive mood (0.71); transcendence of time/space (0.83); and ineffability (0.81). Discussion: The Brazilian Portuguese version of the 
MEQ30 is validated and it fits in the factorial structure performed on the original English version. The SOCQ is also available to the Brazilian Portuguese 
speaking population, allowing studies in different languages to be conducted and compared systematically.
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Introduction
Spirituality is increasingly gaining importance in psychiatry, 
mainly because of a number of recent studies showing the relevance 
of spiritual beliefs, practices and experiences to mental health 
and to the management, treatment and coping with psychiatric 
diseases1-3. These include positive and beneficial effects of 
spirituality in preventing and/or recovering from conditions such 
as drug dependence4-6 or depression7,8.
However, there is still room for debate on the precise meaning 
of the terms “spirituality” or “spiritual”, on how to measure them 
and in the interpretation of the results of such research4,9-11. But far 
from being new, this debate have occupied researchers for decades, 
since at least the lectures of William James in the beginning of 
the last century12. Especially important in James’ proposal was 
the approach to consider that, although different practices and 
traditions vary widely, the core of most spiritual systems involves an 
actual experience, generally called spiritual or mystical experience. 
According to James, such an experience should be a topic for studies 
in psychology and philosophy. This line of inquiry was further 
developed by other important pioneers such as Walter Stace13, who 
expanded and deepened James’ original studies into a coherent 
structure defining what the mystical experience is and what are 
its common features identifiable in many different cultures and 
historical periods. 
While James and Stace developed on the psychological 
description and study of well-known historic cases of mystical 
experiences and their philosophical consequences, Walter Pahnke, 
working in Harvard during the 60’s, developed a practical instrument 
to assess, quantify and determine as precisely as possible the 
occurrence or not of a mystical experience. This work resulted in the 
Mystical Experience Questionnaire (MEQ)14,15, designed based on 
Stace’s conceptual framework about mystical experiences in order 
to evaluate single episodes elicited by psychedelic substances. The 
original MEQ covered the six major dimensions of the mystical 
experience: unity, transcendence of time and space, noetic quality, 
sacredness, positive mood and ineffability/paradoxicality15. In 
Pahnke’s experiment the substance at hand was psilocybin, a naturally 
occurring compound found in Psilocybe mushrooms, long used for 
shamans with spiritual and religious purposes. Since then, the MEQ 
has been used in an expanded version containing distractor items 
unrelated to the mystical experience as defined by Stace’s framework. 
This larger version, including 57 distractor items (in a total of 100 
items), is called the States of Consciousness Questionnaire (SOCQ)15 
and has been used in a series of recent studies with psilocybin16-21. 
More recently, the MEQ has been validated with exploratory15 
and confirmatory16 statistical analysis, resulting in a new version 
which reduced the original 43-item MEQ which contained 6 major 
dimensions to a 30 items MEQ30 containing four factors. 
Although Brazil has played an important role in the study of 
spirituality in psychiatry1-3, there is a current lack of translated and 
validated instruments to assess the mystical experience among 
the Brazilian Portuguese speaking population. Specially regarding 
those occasioned by psychedelic substances such as psilocybin and 
ayahuasca, an amazonian tea used by many indigenous ethnicities, 
such as the Huni Kuin (Kaxinawá) in the State of Acre22 and by 
syncretic churches such as Santo Daime, União do Vegetal (UDV) and 
Barquinha23. In a country where ayahuasca use is rapidly and steadily 
gaining adepts24,25, this lack of questionnaires to develop structured 
research on the theme of substance-related spirituality is detrimental, 
especially for psychology, psychiatry and mental health in general. 
Therefore, it was the aim of the present work to translate the 
SOCQ to Brazilian Portuguese and to validate the Brazilian version 
of the MEQ30, allowing it to be used and employed in future research 
on these topics with Portuguese speaking people.
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Methods
An English version of the 100 items SOCQ was obtained with 
another researcher in the field by email. It was then compared 
with the MEQ version available online17 to verify if the SOCQ 
received actually included all the MEQ questions. The 100 items 
version of the SOCQ was then translated to Brazilian Portuguese 
following the general guidelines in Guillemin26 (Translation 1, 
T1). This translation was done by a Brazilian psychologist (DR), 
with Portuguese as first-language and fluent in English, having 
previously lived and worked for two years in the USA. This 
translator was well aware of the SOCQ’s history and purposes, 
and is involved with research on the theme of consciousness, 
meditation and spirituality. The T1 version was then back 
translated to English (Back translation, BT) by a Brazilian fluent 
in English, having lived 2 years in USA and with more than 30 
years experience in multinational corporations. Each item on the 
BT version was then compared to the corresponding item in the 
original English version by two Brazilian researchers (DR and EES) 
fluent in English and involved with research on consciousness 
and psychedelic substances. All inconsistencies between the 
two English versions were noted and thoroughly discussed. 
This process then led to an update of the Brazilian version (T2) 
following available guidelines26.
The final version of the SOCQ was included in a web-based 
survey platform (SurveyGizmo). Internet social media was used to 
broadcast the survey and to ask people who have used psychedelic 
to answer it anonymously. Participants were asked to answer the 
survey keeping in mind their last experience with a psychedelic 
drug, including classic psychedelics such as LSD and psilocybin, 
ayahuasca, MDMA (“ecstasy”) and also other related substances such 
as ketamine and Salvia divinorum. Cannabis was not considered as a 
psychedelic for this study and answers reporting this substance were 
excluded. Anticholinergics were also not included. Participants had 
to confirm that they were fluent in Brazilian Portuguese to complete 
the survey. After about 30 days of data collection from 31st January 
and 28th February of 2015, 1504 valid answers were completed.
As recently established, the MEQ30 comprises four dimensions, 
or factors: mystical (15 items), positive mood (6 items), transcendence 
of time and space (6 items) and ineffability (3 items). This factor 
structure was submitted to confirmatory factor analysis, assessing 
goodness of fit using five criteria: goodness of fit index (GFI), adjusted 
GFI (AGFI), Bentler Comparative Fit, Bentler-Bonett normed fit 
index (NFI) and root mean square error of approximation (RMSEA) 
estimate. Factors were also submitted to reliability analysis using 
Cronbach’s alpha. Analyses were performed using the Statistical 
Analysis System (SAS) System for Windows (SAS Institute Inc, Cary, 
NC, USA) and R version 3.0.2 (The R Foundation for Statistical 
Computing).
The survey for validation was approved by the Ethics Committee 
of Ethics from the University of Campinas and online respondents 
gave informed consent before starting to fill the form.
Results
Regarding the translation, there was a perfect correspondence 
between the SOCQ received by email with the 43 items of the 
original version of the MEQ available online17. Between the original 
and BT versions of the SOCQ, there were some modifications in the 
title and instructions. The title appeared in BT as “Questionnaire of 
Altered States of Consciousness”, with the introduction of the term 
“altered” revealing a mistake in the first translation to Portuguese 
(T1). This was then corrected by removing “altered” (“alterados”) 
from the title in the updated Portuguese version (T2). All three 
versions, T1, T2 and BT are fully available in the accompanying 
Harvard dataverse (URL:http://dx.doi.org/10.7910/DVN/E8EEC4). 
There were also small changes between the original and BT 
instructions on how to use the questionnaire, without alterations 
of meaning, which can all be consulted in the “instruction changes” 
file in the dataverse. There were differences in 84 items between 
the original English and the BT. The unchanged items are 15, 16, 
21, 37, 43, 45, 49, 52, 60, 64, 65, 68, 70, 87, 88 and 97. Differences 
between BT and the original version for all other items than those 
listed above can be viewed in Table 1 of the dataverse. Common 
differences included the terms sense and feeling, awareness and 
consciousness and also convincing and credible. From the 84 items 
which changed from the original to BT, corrections were done for 
62 items in the Brazilian version T2. These were items 2, 4, 7-10, 
12, 14, 17-20, 22-25, 27, 29, 31, 32, 34, 35, 37, 38, 42-44, 46, 48, 
51, 54-57, 59, 61-63, 65, 66, 68, 69, 72-74, 76, 77, 80-82, 84-87, 
91, 93-97, 99, 100. All these changes are detailed in Table 2 of the 
dataverse. In item 24 a mistake was found in the original version 
received, which states “Feelings of being important than [...]” while 
the correct should be “Feelings of being more important than [...]”. 
In the Brazilian version it was therefore translated as if the original 
was “Feelings of being more important than”.
Concerning the survey for validation of the MEQ, demographic 
characteristics, reported drug and drug setting are detailed in Table 1. 
Education and income were higher than the average Brazilian 
population. Mean age of participants was 28.9 (standard deviation: 
9,1). Male respondents corresponded to 55.6% of the sample. A 
considerable number of different psychedelics were reported, but 
the most frequent answers were ayahuasca (n = 636; 42.3%), LSD 
(n = 535; 35.6%), psychedelic mushrooms or psilocybin (n = 152, 
10.1%), and MDMA or ecstasy (n = 91; 6.1%). 
Table 2 shows the five criteria of goodness of fit that were used, 
two with satisfactory results and the others were close to the cutoff 
point. The standard errors of non-standardized coefficients showed 
values different from zero, indicating adequacy of fit. Also, the 
distribution of normalized residuals is symmetrical. Considering all 
these characteristics of the model, it was considered acceptable for 
our dataset. The theoretical structure for the MEQ that was tested, 
with factors, items and loads are detailed in Table 3. In the reliability 
analysis, one factor presented excellent (α ≥ 0.9), two good (0.9 > α 
≥ 0.8) and one acceptable (0.8 > α ≥ 0.7) reliability. Cronbach’s alpha 
for the four factors were as following: mystical (0.95); positive mood 
(0.71); transcendence of time/space (0.83); and ineffability (0.81).
Discussion
Translation
The comparison between the original English version with the back 
translation revealed few errors in the first translation (T1), which 
could easily be corrected generating a reliable Brazilian Portuguese 
version of the full 100 item SOCQ. Of special importance, however, 
is the translation of the English terms consciousness and awareness, 
both of which translate to the same Brazilian Portuguese word: 
consciência. Although there is a different usage in English for 
these two words, the exact difference is hard to specify, and there 
are different options about them in the English language. The 
Oxford Dictionary for example defines consciousness as “the 
state of being aware of and responsive to one’s surrounding” or 
as “a person’s awareness or perception” of something. Awareness, 
on the other hand, is defined as “knowledge or perception of a 
situation or fact” or as “concern about and well-informed interest 
in a particular situation or development”. These definitions make 
it clear the similarity between these two terms in English, with 
both definitions of consciousness including the word aware (or 
awareness). However, there seems to be a crucial difference, 
with consciousness including, but not being equal to, awareness. 
In this regard, for instances where awareness was translated as 
consciência and therefore back translated as consciousness, there 
might be differences in meaning which are very important to the 
subject under study while using the SOCQ. Therefore, following 
the above definitions for awareness, which include the concept of 
perception or well-informed interest, we changed the translation 
of items 74 and 95 from consciência to percepção, for which the 
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Table 1. Demographic information and information about psychedelic experience evaluated with the States of Consciousness Questionnaire/30-item 
Mystical Experience Questionnaire (n = 1504), Jan-Feb 2015 
Demographic information Information about the reported psychedelic experience
n % n %
Sex Substance used
Male 836 55,6% Ayahuasca 636 42,3%
Female 668 44,4% Mushrooms/psilocybin 152 10,1%
Age LSD 535 35,6%
18-21 343 22,8% MDMA/ecstasy 91 6,1%
22-28 513 34,1% DMT/changa 22 1,5%
29-40 489 32,5% Peyote/wachuma/mescaline 18 1,2%
≥ 41 159 10,6% Argyreia nervosa/LSA 17 1,1%
Educational level Salvia divinorum 11 0,7%
Elementary or less 49 3,3% Jurema 10 0,7%
High school 709 47,1% 25-NBOMe 6 0,4%
University 559 37,2% Other 6 0,4%
Masters/Doctorate 187 12,4%
Monthly income (US$) Time since experience
< 525 137 9,1% < 24 hours 117 7,8%
   525-950 292 19,4%  24 - 48 hours 77 5,1%
   951-1660 368 24,5% 48 hours - 1 week 162 10,8%
   1661-3510 417 27,7%  1 week - 1 month 405 26,9%
   3511-6180 197 13,1% 1 - 6 months 341 22,7%
> 6180 93 6,2%  6 months - 1 year 105 7,0%
Occupational status > 1 year 297 19,7%
Student 471 31,3%
Employee 301 20,0%
Freelancer 296 19,7% Ritual use
Civil servant 179 11,9% No 843 56,1%
Businessman 121 8,0% Yes 661 43,9%
Unemployed 87 5,8%
Other 49 3,3%
Has a religion Guided use
No 1.089 72,4% No 760 50,5%
Yes 415 27,6% Yes 744 49,5%
Table 2. Goodness-of-fit indexes from the confirmatory factor analysis of the Brazilian Portuguese version of the 30-item Mystical Experience Questionnaire 
in 1504 subjects, Jan-Feb 2015
Index Estimate Reference
Goodness-of-fit index (GFI) 0.8387 ≥ 0.85
Adjusted GFI 0.8101 ≥ 0.80
Bentler comparative fit index 0.8751 ≥ 0.90
Bentler-Bonett normed fit index 0.8620 ≥ 0.90
Root mean square error of approximation estimate 0.0733 ≤ 0.08
literal back translation would be perception. The term “percepção” 
seems a more adequate translation for awareness in some cases, 
being considered a synonym for it, which consciousness is not. On 
the other hand, in items 3, 19, 29, 41 and 99 we opted to maintain 
the word “consciência” as the translation of “awareness” because 
it seems to better preserve the meaning of the original items. It is 
difficult to establish at this point, however, if this option is really 
the best match for the meaning of awareness and if we would be 
measuring similar concepts when using the present Brazilian 
version of the Questionnaire. This can only be assessed in a 
future study actually applying the questionnaire to people who 
had mystical like experiences, in order to statistically validate 
it according to previous research already done for the English 
version15. Most of the remaining differences between the original 
questionnaire and the BT version are of minor significance, not 
affecting the understanding of the sentences nor the meaning of 
it. It is our hope that the updated version presented in this article 
have solved all of these.
Validation
Regarding the survey for validation of the MEQ30, some 
limitations must be kept in mind. This study has a population 
that is better educated and has a higher income comparing to 
the average Brazilian population. On the other hand, this sample 
seems to be representative of ritual and recreational users of 
psychedelics in Brazil. This also makes this sample more similar 
to samples in higher income countries. Though this is useful for 
comparison, one must proceed with caution in Brazilian samples 
with lower income and educational level. Also, considering that 
4 Schenberg EE et al. / Arch Clin Psychiatry. 2017;44(1):1-5
Table 3. Factors and items and respective factor loads of the confirmatory factor analysis of the Brazilian Portuguese version of the 30-item Mystical 




35. Freedom from the limitations of your personal self and feeling a unity or bond with what was felt to be greater than your personal self. 0.85
41. Experience of pure being and pure awareness (beyond the world of sense impressions). 0.83
54. Experience of oneness in relation to an “inner world” within. 0.86
77. Experience of the fusion of your personal self into a larger whole. 0.81
83. Experience of unity with ultimate reality. 0.87
12. Feeling that you experienced eternity or infinity. 0.81
External Unity 
14. Experience of oneness or unity with objects and/or persons perceived in your surroundings. 0.79
47. Experience of the insight that “all is One”. 0.86
74. Awareness of the life or living presence in all things. 0.85
Noetic Quality 
9. Gain of insightful knowledge experienced at an intuitive level. 0.72
22. Certainty of encounter with ultimate reality 0.85
69. You are convinced now, as you look back on your experience, that in it you encountered ultimate reality 0.81
Sacredness 
36. Sense of being at a spiritual height. 0.85
55. Sense of reverence. 0.80
73. Feeling that you experienced something profoundly sacred and holy. 0.87
Factor 2: Positive Mood 
5. Experience of amazement. 0.88
18. Feelings of tenderness and gentleness 0.66
30. Feelings of peace and tranquility. 0.73
43. Experience of ecstasy 0.85
80. Sense of awe or awesomeness. 0.88
87. Feelings of joy. 0.90
Factor 3: Transcendence of Time and Space 
2. Loss of your usual sense of time. 0.71
15. Loss of your usual sense of space. 0.73
29. Loss of usual awareness of where you were. 0.46
34. Sense of being “outside of” time, beyond past and future. 0.74
48. Being in a realm with no space boundaries. 0.80
65. Experience of timelessness. 0.83
Factor 4: Ineffability 
6. Sense that the experience cannot be described adequately in words. 0.87
23. Feeling that you could not do justice to your experience by describing it in words. 0.95
86. Feeling that it would be difficult to communicate your own experience to others who have not had similar experiences. 0.79
almost 20% of the subjects reported use of psychedelics more than 
one year ago, recall bias can be present and influence this data. As 
in Brazil some psychedelics reported in this survey, like LSD and 
MDMA, are illicit, it is impossible to assess if ‘LSD’ or ‘MDMA’ 
users really used these substances or others that might be present 
in the materials obtained in the illegal market. 
On the other hand, the sample is very diverse in terms of profile of 
substances used and their respective settings, and included ritual and 
recreational users, either in guided or non-guided experiences, and in 
a vast array of drugs, though the most common were ayahuasca, LSD, 
psilocybin and MDMA. This variability is desirable in a validation 
study, and the high number of respondents represent the largest 
Brazilian sample of psychedelic users assessed and reported so far. 
Taking all this in consideration and examining the results from 
the confirmatory factor analysis and the reliability analysis, we can 
affirm that the Brazilian version of the MEQ30 both fits the original 
model and is a reliable questionnaire.
Given the recent increase in interest in ayahuasca studies in Brazil 
and the increased interest in psychedelic studies internationally, 
we hope this publication helps to better investigate the occurrence 
or not of well-defined and measured spiritual experiences in 
practices with ayahuasca or studies involving psychedelics like 
psilocybin17-21 or with other psychedelics such as the phenethylamine 
3,4-Methylenedioxyamphetamine (MDA)27. Furthermore, although 
the SOCQ/MEQ has been used mostly in studies with this kind of 
psychoactive substances, the MEQ30 may be of interest to researchers 
interested in the theme of spirituality and states of consciousness 
in other settings not necessarily involving the use of psychoactive 
substances.
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